Dario Amodei Is Wrong About AI
Dario Amodei Is Wrong About AI
YouTube10 min 7 sec
Watch on YouTube
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights
  • Consider a diversified semiconductor investment for exposure to AI growth; the outlook is cautiously bullish, but avoid relying on NVIDIA (NVDA) alone because more efficient models and future technologies could pressure chip demand.
  • Meta Platforms (META) is a higher-conviction AI-product idea, with its distribution and product capabilities potentially helping it turn AI into services; no price target or timeframe was provided.
  • Treat photonic computing as a long-term theme, not a near-term trade: the discussion suggested a roughly 20-year horizon and named no investable companies.
Detailed Analysis

NVIDIA (NVDA)

  • Shkreli said he is long semiconductors, while cautioning that NVIDIA could face pressure if AI models become much more efficient.
    • He cited the possibility of transformers becoming 1,000 times more efficient as a reason demand for NVIDIA’s chips could be lower than expected.
    • He expects today’s H100, B100, and B200 chips to become obsolete over time, and said photonic computing could eventually offer a better approach.
    • He also argued that demand for compute may keep growing because businesses have substantial demand for intelligence and work. However, he questioned whether compute needs could grow by a million times.

Takeaways

  • The discussion presents a mixed outlook for NVIDIA: growing AI use could support chip demand, but more efficient models or new computing technologies could reduce the amount of hardware needed.
  • For investors, the key issue raised is whether efficiency gains will be outweighed by new uses for AI. Shkreli did not give a price target or a specific holding period.

Semiconductor Sector

  • Shkreli said he is long semiconductors and expressed a generally positive view of the sector’s role in the AI buildout.
  • He also warned that picking the lasting winners is difficult, comparing the challenge to investors in 2000 who might have assumed Yahoo and Cisco would remain winners.
  • He described the current investment outlook as uncertain, despite his long position.

Takeaways

  • The transcript supports a cautiously bullish but uncertain view of semiconductors: AI demand may create opportunities, but today’s leaders may not capture the benefits indefinitely.
  • The risk highlighted is winner selection—investors may be right about AI growth but wrong about which companies ultimately earn the most from it.

Photonic Computing

  • Shkreli said photonic computing could be a better way to perform computing in the future and suggested that today’s GPU generations could eventually be replaced.
  • He referred to a 20-year horizon for the idea and noted that Sam Altman had publicly described photonic computing as a potential future technology.

Takeaways

  • Photonic computing is presented as a long-term technology theme, not a near-term investment recommendation.
  • No specific companies or securities were named, and the transcript gives no details on commercialization timing beyond Shkreli’s broad 20-year framing.

Meta Platforms (META)

  • Shkreli described the timing as favorable for Meta, pointing to its distribution and product capabilities.
  • He cited Meta’s Muse product work as evidence that the company may be able to create new AI-enabled products.
  • He also praised Meta for publicly pushing back against what he views as exaggerated fears about AI.

Takeaways

  • Shkreli’s comments were bullish on Meta’s ability to turn AI into products, particularly by using its existing distribution.
  • The transcript does not include a price target, valuation analysis, or specific recommendation to buy Meta shares.

OpenAI and Anthropic

  • When asked whether he would buy OpenAI and Anthropic, Shkreli said yes.
  • He argued that AI opportunities could extend beyond knowledge work and that AI firms might eventually build businesses across sectors such as pharmaceuticals, motors, and aviation.
  • He also said Sam Altman’s move toward hardware could help OpenAI deliver its models, not just develop them.
  • Separately, he said the AI market may resemble the internet: consumers and businesses could capture much of the benefit, while only some technology providers earn substantial returns.

Takeaways

  • Shkreli expressed a bullish view of AI’s long-term potential, but also suggested that broad economic benefits do not guarantee that AI providers will be the biggest financial winners.
  • OpenAI and Anthropic are not publicly traded companies, and the transcript does not identify a specific public security or investment vehicle.

Core Automation

  • Shkreli said he was excited about Core Automation, a startup founded by a former OpenAI employee whom he described as having invented OpenAI’s reasoning model.
  • He linked the company to the broader idea that AI could start and operate businesses across multiple industries.

Takeaways

  • Core Automation is a private startup opportunity mentioned favorably, but the transcript provides no financial details, valuation, or way for the general public to invest.
  • The idea is speculative: the discussion describes a potential business model, not evidence that it has been proven at scale.

AI in Drug Discovery

  • Shkreli strongly disputed claims that AI would quickly transform drug discovery. He said he did not expect an AI-relevant drug in the next 10 years and argued that computing tools have not removed the difficulty of developing drugs.
  • He acknowledged that GPUs can help with analysis but said he sees limited help from AI in drug discovery.
  • He also criticized claims that AI would cure diseases, treating those claims as excessive or unsubstantiated.

Takeaways

  • Shkreli’s view on AI-enabled drug discovery was bearish and skeptical, especially regarding near-term expectations.
  • The transcript names no pharmaceutical stock or specific drug-development investment. His comments are a caution against assuming that AI adoption will quickly translate into successful medicines.

AI Investment Theme

  • Shkreli argued that demand for intelligence and work could be very large, including from businesses willing to spend heavily on AI if it improves decisions or productivity.
  • He said he does not see the AI valuation environment as necessarily a “valuation trap,” but acknowledged uncertainty about how long individual companies can earn outsized returns.
  • He called the recent market sell-off “ridiculous,” though no specific security or index was identified.

Takeaways

  • The discussion is bullish on the potential size of the AI market, but more cautious about identifying which companies will capture the value.
  • The practical distinction raised is between AI adoption and investment returns: broad usage may benefit consumers and businesses without guaranteeing lasting profits for every AI provider.
Ask about this postAnswers are grounded in this post's content.
Video Description
I explain why I disagree with Dario Amodei's outlook on AI, where I see the investment opportunities, and why I'm optimistic about AI's commercial potential. We discuss NVIDIA, the future of computing, effective altruism, AI drug discovery, and whether demand for intelligence has a limit. I also share my views on Meta, OpenAI, AI safety, and how AI could create entire businesses. From my interview at the All-In Summit. Watch the original interview on The All-In Podcast: https://www.youtube.com/watch?v=yZR8QW4qQmM 00:00 NVIDIA and future AI computing 01:34 My portfolio approach 02:07 Dario Amodei and AI pessimism 03:31 Effective altruism vs. accelerationism 04:55 My view on AI drug discovery 05:24 Demand for intelligence and AI-created companies 07:16 Who wins in the AI market? 08:58 AI safety and competitor peer review Join me on Godel Terminal: https://app.godelterminal.com/?page=register&via=BIG Godel Terminal: https://godelterminal.com LINKS: X: https://x.com/martinshkreli GitHub: https://github.com/martinshkreli Discord: https://discord.com/invite/martinshkreli TikTok: https://www.tiktok.com/@martinshkreli15 Instagram: https://www.instagram.com/martinshkreli15/ LinkTree: https://linktr.ee/martinshkreli
About Martin Shkreli
Martin Shkreli

Martin Shkreli

By @realmartinshkreli

Investing, music, science, math, technology, programming, medicine and more!